MediXall™ Group, Inc. Announces Strategic Agreement with Renaissance Health System of Florida, Inc.(RHSFL)

MediXall Group, Inc. Announces Program to Enlist Diagnostic Centers to Support Its MediXaid(TM) Electronic Healthcare Marketplace Platform
February 10, 2017
MDXL Announces the Successful Launch of Program to Enlist Healthcare Providers to Its Network
March 7, 2017

(Fort Lauderdale, FL, February 21, 2017) (Marketwired) MediXall Group Inc., (“MediXall”), is a technology and innovation-driven organization structured to bring effective change to the U.S. healthcare industry.
MediXall today has signed a Strategic Agreement with Renaissance Health System of Florida, Inc. (RHSFL) that would provide MediXall with access to more than 2,000 healthcare providers in the State of Florida. Together, these more than 2,000 healthcare providers comprise one of the largest credentialed provider networks within geographic areas that include more than 70% of the nearly 21 million residents in the State.
The agreement calls for MediXall, in collaboration with RHSFL, to contact this provider network and offer them the opportunity to be “early adopters” on the MediXaid™ e-commerce platform presently in development. RHSFL had identified and credentialed some of the best healthcare practices in wide range of fields throughout the 37 counties in Florida; practices that range from diagnostic centers, primary care, specialty care, as well as ancillary care physician practices.
Carl L. Larsen, MediXall Chief Operating Officer, noted that over a five-year period RHSFL developed and maintained one of the most enviable networks of healthcare providers in the State of Florida. “We will use the access to these providers to bring them onboard in what we believe will be a revolutionary new healthcare marketplace providing consumers the free market competition to achieve the best cost, high transparency and a convenient and uncomplicated internet accessible platform that meets the requirements of today’s discriminating consumer. Our marketing campaign is being finalized and will begin shortly in anticipation of the launch of our MediXaid™ platform by the summer of 2017.”
MediXaid™, conceived with the cooperation of its development partner, The Quantum Group, Inc. (QGP) and owner of a robust electronic healthcare record system platform and technology portfolio containing 13 granted patents, 18 pending patents and nearly 1,000 combined patent claims is poised to bring transparency and free market competition to the healthcare industry. The platform will offer consumers and corporations, such as self-insured companies operating under ERISA (Employee Retirement Security Act of 1974) and private insurance companies, the ability to cost compare, price and sort for medical services and products by price, first available appointment and nearest location. MediXall has completed development of the platform prototype and expects to launch the platform by the end of Q2 2017.
About MediXall Group, Inc.
MediXall Group, Inc. is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry. The Company believes its revolutionary approach will help drive much needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody it’s mission statement. MediXall’s first acquisition was MediXaid™, a developing cloud-based software platform that promises to revolutionize the way people purchase healthcare goods and services.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Neil Swartz President and CEO of MedIXall Group, Inc.
(954) 908-3481 <>

Leave a Reply